Lion Street Advisors’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	$526K	Buy	4,212 +64	+2%	+$5.76K	0.18%	107
2025 Q2	$344K	Sell	4,148 -220	-5%	-$17.6K	0.1%	200
2025 Q1	$354K	Sell	4,368 -25	-0.6%	-$2.23K	0.11%	186
2024 Q4	$396K	Buy	4,393 +450	+11%	+$43.6K	0.13%	165
2024 Q3	$390K	Sell	3,943 -300	-7%	-$29.5K	0.14%	167
2024 Q2	$393K	Buy	4,243 +1	+0%	+$90	0.15%	151
2024 Q1	$379K	Hold	4,242	–	–	0.15%	143
2023 Q4	$379K	Sell	4,242 -300	-7%	-$22.3K	0.16%	143
2023 Q3	$332K	Buy	4,542 +320	+8%	+$25.6K	0.11%	163
2023 Q2	$527K	Sell	4,222 -366	-8%	-$30.6K	0.18%	113
2023 Q1	$350K	Buy	4,588 +1,277	+39%	+$106K	0.11%	156
2022 Q4	$413K	Sell	3,311 -105	-3%	-$8.5K	0.22%	75
2022 Q3	$273K	Buy	3,416 +105	+3%	+$8.85K	0.14%	97
2022 Q2	$406K	Sell	3,311 -15	-0.5%	-$1.13K	0.21%	80
2022 Q1	$298K	Sell	3,326 -30	-0.9%	-$2.77K	0.15%	105
2021 Q4	$374K	Buy	3,356 +45	+1%	+$5.43K	0.18%	88
2021 Q3	$417K	Buy	+3,311	New	+$426K	0.23%	73